The Great Swine Flu Boondoggle

Theso-called great Swine flu pandemic is nothing more than a One WorldGovernment power grab, an effort at population control and a boondoggledesigned to enrich big Pharma and its supporters.

While the United States Centers for Disease Control and Prevention(CDC), the World Health Organization (WHO) and the President’s Councilof Advisors on Science and Technology are predicting millions ofinfections and tens of thousands of deaths to come, actual figuresearly in the season are proving to be quite different.

Amidst all the ballyhoo, big Pharma has ramped up production ofvaccines and governments are threatening to mandate—and in the case ofthe New York and New Jersey actually mandating—forced immunizations.

The virus, first called Swine flu and later name-changed to H1N1,first appeared in Mexico in April. Since then the WHO has declared thedisease a pandemic. But as of Sept. 25, according to the WHO, therehave been only 318,925 confirmed cases worldwide and only 3,917 deaths;a mortality rate of just over 1 percent. That’s a truly minisculenumber. Don’t forget the seasonal flu kills an average of 3,000 peopleper month in the U.S. alone.

As late as August, the President’s Council of Advisors on Sciencepredicted the H1N1 virus would infect 2 million U.S. citizens this falland winter and result in 30,000 to 90,000 U.S. deaths.

While the flu so far is proving troublesome for those who have itand causing a higher than normal percentage of absenteeism in schoolsacross the U.S., its effects are turning out much milder thangovernment propagandists forecast.

This is not the first time for predictions by governmentscare-mongers of a worldwide Swine flu pandemic. In 1976, after onesoldier at Fort Dix, N.J., collapsed during a 50 mile hike and laterdied, the U.S. government ramped up a Swine flu vaccine and through amassive public relations campaign, encouraged everyone in the countryto be vaccinated.

This despite the fact that all known cases of Swine flu at the timewere confined to 155 soldiers at Fort Dix, and none of them died.

In March of 1976, two months after the soldier’s death and withseasonal flu cases in their normal decline, the CDC asked Congress forthe money to develop enough vaccine to immunize 80 percent of the U.S.population.

Four months later Congress was pushing drug companies to workfaster, and drug companies asked for immunity from lawsuits ifsomething went wrong with the vaccine. On Aug. 2, 1976, two members ofthe American Legion died from a respiratory disease acquired at theLegion’s convention in Philadelphia and the next day, convinced that anepidemic was beginning, Congress granted the immunity drug companiessought.

Two months later, with the government predicting at least a milliondeaths to come from the Swine flu, the immunization process began. ByOct. 11, 1976, approximately 40 million people had been vaccinated.Then three seniors died soon after receiving their shots.

In the ensuing days more seniors died and many otherwise healthypeople began suffering debilitating neuromuscular problems andparalysis which later was diagnosed as Guillan-Barré syndrome. TheSwine flu immunization was the common factor in the cases.

Drug companies that manufactured the vaccines made millions yetsuffered no liability for the consequences of their untested vaccine.

It turned out in 1976 that the cure was more deadly than thedisease. It looks like the same is probably going to be true this time.

The drug company GlaxoSmithKline was recently contracted by Canadato manufacture 50.4 million doses of Swine flu or H1N1 vaccine. Drugcompanies Baxter Pharmaceuticals and Novartis Pharmaceuticals have beencommissioned to manufacture the vaccine for the U.S.

Both GlaxoSmithKline and Novartis are using the substance squalene in their H1N1 vaccines. According to The American Journal of Pathology,squalene is a cholesterol precursor which stimulates the immune systemnonspecifically. One intradermal injection—or shot—of this adjuvantlipid can induce joint-specific inflammation in arthritis-prone rats.

Novartis’ squalene adjuvant was used in the experimental anthraxvaccines for soldiers serving in the Gulf War and has been linked toGulf War Syndrome, the devastating auto-immune disease suffered by GulfWar veterans who took the anthrax shots.

Symptoms of Gulf War Syndrome include ulcers, arthritis, chronicdiarrhea, fatigue and headaches, dizziness, fibromyalgia, memory loss,mood changes, multiple sclerosis, neuropsychiatric problems, rashes,skin lesions, photosensitive rashes and systemic lupus, according toosteopathic physician Joseph Mercola, M.D.

On Dr. Mercola’s website, anthrax vaccine expert Meryl Nass, M.D., wrote:

A novel feature of the two H1N1 vaccines being developedby companies Novartis and GlaxoSmithKline is the addition ofsqualene-containing adjuvants to boost immunogenicity and dramaticallyreduce the amount of viral antigen needed. This translates to muchfaster production of desired vaccine quantities.

Dr. Nass also writes that the squalene adjuvants have not beenapproved by the Food and Drug Administration (FDA) for use in any U.S.vaccine.

And then there’s Baxter.

In 2008, Baxter produced a contaminated blood thinner called heparinthat had to be recalled by the FDA. It resulted in at least 81 deathsand hundreds of injuries. The active ingredient for heparin wasproduced in a Chinese factory that had never been inspected by the FDA.

Earlier this year it was reported that Baxter shipped what could bea weaponized version of the H591 Avian flu virus to at least 18countries in a vaccine. The vaccine contained a live virus that hadbeen mixed with seasonal flu viruses. The combination would havecreated a super-strain of virus that would have spread much morereadily than normal Avian flu.

Curiously, Baxter applied for a patent for the H1N1 flu vaccine inAugust 2008, eight months before the H1N1 virus appeared in Mexico.This for a type of virus that had not manifested itself for more than30 years.

In July the drug companies were given immunity from liability forthe vaccines and the immunizations are about to begin with very littletesting. Again, drug companies stand to make millions of dollarswithout fear of consequences if things go horribly wrong.

Appearing suddenly in April, the origins of the virus have eithernot been discovered or are known but not being revealed to the generalpublic. Writing for the Institute of Science in Society, ProfessorAdrian Gibbs and Dr. Jean Downie have studied the gene sequences of theH1N1 virus and determined the virus is a combination unlike any seen inthe past.

Furthermore, none of the genes that make up the virus have been seenfor a long time. It appears to be a combination of Swine flu not seenin North America in more than a decade and Avian flu found in Europebut never in North America.

Gibbs and Downie posit the virus emanated either from a vaccine madespecifically for pigs, accidentally from an infected human working fora drug company or intentionally released into the Mexican population.

Remembering the scare that didn’t materialize in 1976 andrecognizing the hyperbole coming out of government organizations, manyAmericans are casting a wary eye toward the prospects of vaccination.Many of those are saying no immunization, no way.

Recognizing that their scaremongering tactics aren’t working,governments are now starting to ramp up their intimidation tactics. NewYork just decreed that all health workers are required to be immunizedand New Jersey has mandated the same for all children in day care andpreschool.

Presidential advisor and former Congressman Rham Emanuel oncestated, “You should never want a serious crisis to go to waste.” Thosecurrently in charge are doing their dead-level best not to waste thismanufactured one.

If government gets away with forcing its citizens to receive a drugagainst their will, one more chunk will have been removed from the wallseparating liberty from tyranny.